anethole has been researched along with Metastase in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahn, JC; Chung, PS; Kim, SH; Rhee, YH | 1 |
Chen, CY; Choo, EJ; Jeong, SJ; Jung, JH; Kim, DK; Kim, HS; Kim, JH; Kim, SH; Ko, HS; Kwon, TR; Lee, EO; Lee, HJ; Rhee, YH | 1 |
2 other study(ies) available for anethole and Metastase
Article | Year |
---|---|
CXCR4 and PTEN are involved in the anti-metastatic regulation of anethole in DU145 prostate cancer cells.
Topics: Allylbenzene Derivatives; Anisoles; Anticarcinogenic Agents; Cell Line, Tumor; Cell Survival; Down-Regulation; Humans; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Neoplasm Metastasis; Phosphatidylinositol 3-Kinases; Phosphorylation; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Receptors, CXCR4; RNA, Messenger; RNA, Neoplasm; RNA, Small Interfering; Signal Transduction; Up-Regulation | 2014 |
Anethole exerts antimetatstaic activity via inhibition of matrix metalloproteinase 2/9 and AKT/mitogen-activated kinase/nuclear factor kappa B signaling pathways.
Topics: Allylbenzene Derivatives; Animals; Anisoles; Cell Line, Tumor; Dose-Response Relationship, Drug; Humans; Matrix Metalloproteinase Inhibitors; Mitogen-Activated Protein Kinase Kinases; Molecular Structure; Neoplasm Metastasis; NF-kappa B; Proto-Oncogene Proteins c-akt; Signal Transduction | 2011 |